Related Experiment Videos
Treatment of chemotherapy-refractory metastatic urothelial tumors
1Department of Medical Oncology, U.T. M. D. Anderson Cancer Center, Houston.
The Urologic Clinics of North America
|November 1, 1992
Abstract:
Patients with unresectable bladder carcinoma unresponsive to standard chemotherapy have a short survival, but recent clinical trials of salvage treatment have produced some good results. Changes in the dosage of M-VAC; 5-fluorouracil, alpha-interferon, and cisplatin; and gallium nitrate show promise.